Channel Therapeutics Corporation (CHRO) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 416.34M |
| Enterprise Value | 432.56M |
| P/E Ratio | -0.05 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.32 |
| Price/Book Ratio | 0.13 |
| Enterprise/Revenue | 0.1 |
| Enterprise/EBITDA | -0.07 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.86 |
| Operating Margin | -0.8 |
| Return On Assets | -0.35 |
| Return On Equity | -1.64 |
| Revenue | 16.8M |
| Revenue/Share | 8.36 |
| Gross Profit | 0 |
| EBITDA | 2.29M |
| Net Income | -43.32M |
| Diluted EPS | -23.04 |
| Total Cash | 31.98M |
| Total Cash/Share | 9.66 |
| Total Debt | 25.94M |
| Total Debt/Equity | 0.74 |
| Current Ratio | 2.79 |
| Book Value Per Share | 10.6 |
| 52-Week Change | -87.38 |
| 52-Week High | 54.29 |
| 52-Week Low | 1.23 |
| Moving Average 50 Days | 12.03 |
| Moving Average 200 Days | 12 |
| Average Volume | 111,305 |
| Shares Outstanding | 6.6M |
| % Held by Institutions | 0.24 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 02, 2025 |